In developing countries, 6 out of 10 people die from infectious diseases. Nearly 1
billion humans suffer from a neglected infectious disease, according to the World
Health Organisation. Yet less than 1% of the new drugs placed on the market from 1975
to the turn of the century were developed for these diseases. This book looks at ways
of improving the availability of medicines for infectious diseases through strengthened
coherence in health, trade, science and technology, development co-operation and finance.